RxDoctor Payments Data

Kelly Vo

Nurse Practitioner · Harriman, TNNPI 1275019606

Payments from drug & device makers

$1,405in general payments, 2019–2025

Across 84 payments — averaging $16.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$414
  • Lilly USA, LLC$245
  • Novo Nordisk$170
  • Teva Pharmaceuticals USA, Inc.$163
  • Otsuka America Pharmaceutical, Inc.$90
  • AstraZeneca$76
  • plus $247 from 11 others

What the payments were for

  • Food & beverage$1,39299%
  • Education$131%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,405 in reported general payments places this provider in the 75th percentile of 2,662 nurse practitioner providers in Tennessee.

See all nurse practitioner providers in Tennessee

Medicare billing

Part B allowed, 2024
$25,766
Medicare patients
53
Services billed
331

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide110$120,988
OzempicSemaglutide59$90,862
JardianceEmpagliflozin59$67,939
Trelegy ElliptaFluticasone/Umeclidin/Vilanter44$47,286
TrulicityDulaglutide19$34,938
VraylarCariprazine Hcl23$34,063
EliquisApixaban22$25,547
UbrelvyUbrogepant11$18,945
Breztri AerosphereBudesonide/Glycopyr/Formoterol22$18,105
SymbicortBudesonide/Formoterol Fumarate59$18,101
LinzessLinaclotide24$17,007
Spiriva HandihalerTiotropium Bromide18$14,404
Spiriva RespimatTiotropium Bromide16$11,852
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen209$9,295
Albuterol Sulfate HfaAlbuterol Sulfate261$6,240

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$245$155,926129 claims
Novo NordiskOzempic$170$90,86259 claims
Boehringer IngelheimJardiance, Spiriva Respimat$18$79,79175 claims
AbbVieVraylar, Ubrelvy, Linzess$414$70,01658 claims
GSKTrelegy Ellipta$12$47,28644 claims
AstraZenecaBreztri Aerosphere, Symbicort$76$36,20681 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 2,662 nurse practitioner providers in Tennessee.

Other nurse practitioner in Harriman

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →